Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 19451-19500 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06552429
Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET
PHASE2Recruiting
27 participants
Started: Aug 29, 2024 · Completed: Sep 30, 2027
1 condition1 sponsor8 locations
NCT05330182
LMN-201 for Prevention of C. Difficile Infection Recurrence
PHASE2/PHASE3Recruiting
375 participants
Started: Aug 29, 2024 · Completed: Apr 1, 2026
1 condition2 sponsors17 locations
NCT06573372
Evaluating the Diagnostic Efficacy of Smartwatch and Smartphone for Sleep Apnea
N/ARecruiting
295 participants
Started: Aug 29, 2024 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT06585527
Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
PHASE1Recruiting
30 participants
Started: Aug 29, 2024 · Completed: Jan 1, 2026
2 conditions1 sponsor1 location
NCT06433401
The Effect of Structured Transition Care Model Applied to Adolescents With Congenital Heart Disease
NARecruiting
70 participants
Started: Aug 29, 2024 · Completed: Mar 30, 2025
1 condition1 sponsor2 locations
NCT04962087
Health enSuite Insomnia: an App-based Treatment for Adult Chronic Insomnia
NARecruiting
415 participants
Started: Aug 29, 2024 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT06554886
A Study Investigating Peripheral Cryoneurolysis in Adults With Chronic Migraine
NARecruiting
12 participants
Started: Aug 29, 2024 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT06452355
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
NARecruiting
72 participants
Started: Aug 29, 2024 · Completed: Aug 30, 2026
3 conditions1 sponsor14 locations
NCT06611943
DietCoach: Development and Dietitian Evaluation of a Digital Dietary Counseling Platform
N/ARecruiting
30 participants
Started: Aug 29, 2024 · Completed: Dec 30, 2024
4 conditions2 sponsors1 location
NCT06497010
An Exploratory Study of Individualized Neo-antigen mRNA Cancer Vaccine InnoPCV in Advanced Solid Tumor Treatment
EARLY_PHASE1Recruiting
40 participants
Started: Aug 29, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06881810
Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment
PHASE2Recruiting
98 participants
Started: Aug 29, 2024 · Completed: Mar 31, 2028
1 condition1 sponsor1 location
NCT06766279
Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19
NARecruiting
32 participants
Started: Aug 29, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06557772
A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
PHASE2Recruiting
204 participants
Started: Aug 29, 2024 · Completed: Apr 10, 2029
2 conditions1 sponsor111 locations
NCT06347432
Em-power: Maximizing Functional Independence for Children with Severe Cerebral Palsy
NARecruiting
16 participants
Started: Aug 29, 2024 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06566690
The Association Between Sensory Block Level, Oxygen Therapy, and ORi in Varicose Vein Patients Undergoing Spinal Anesthesia (ORi: Oxygen Reserve Index)
N/ARecruiting
56 participants
Started: Aug 29, 2024 · Completed: Oct 10, 2025
2 conditions1 sponsor1 location
NCT07066033
A Study of the Intestinal Microbiota in Children and Adolescents With Eating Disorders. A Perspective From Psychoneuroimmunology
N/ARecruiting
158 participants
Started: Aug 29, 2024 · Completed: Aug 31, 2027
2 conditions3 sponsors2 locations
NCT06347731
Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan)
NARecruiting
47 participants
Started: Aug 29, 2024 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06699979
Multi-omics Study of Early-stage Lung Cancer with Distinct Phenotypes
N/ARecruiting
300 participants
Started: Aug 29, 2024 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT05785065
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
PHASE2Recruiting
35 participants
Started: Aug 29, 2024 · Completed: Dec 31, 2028
3 conditions7 sponsors3 locations
NCT06590012
Evaluating the Impact of 'Tertinat' on Patients with Atherosclerosis-Related Cardiovascular Diseases
PHASE2Recruiting
556 participants
Started: Aug 29, 2024 · Completed: Mar 1, 2026
3 conditions1 sponsor1 location
NCT06586047
Breast Cancer PSMA PET
NARecruiting
30 participants
Started: Aug 29, 2024 · Completed: Aug 29, 2026
1 condition2 sponsors1 location
NCT06445959
Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib
PHASE1/PHASE2Recruiting
78 participants
Started: Aug 29, 2024 · Completed: Jun 30, 2029
1 condition2 sponsors1 location
NCT06442475
Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
PHASE2Recruiting
20 participants
Started: Aug 29, 2024 · Completed: Feb 12, 2027
9 conditions1 sponsor1 location
NCT06573034
Daoist Zhanzhuang and Human Flourishing
NARecruiting
120 participants
Started: Aug 29, 2024 · Completed: Jul 31, 2027
4 conditions1 sponsor1 location
NCT06235437
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASD141
PHASE1Recruiting
21 participants
Started: Aug 29, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT06380075
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
NARecruiting
50 participants
Started: Aug 29, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05397691
Substance Use Prevention for Youth With Parents in Recovery
NARecruiting
80 participants
Started: Aug 29, 2024 · Completed: Mar 31, 2026
1 condition3 sponsors1 location
NCT06499623
Early Detection of Malnutrition in Oncology Patients and Elderly Patients
N/ARecruiting
2,000 participants
Started: Aug 29, 2024 · Completed: Mar 31, 2026
1 condition10 sponsors9 locations
NCT06331299
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
PHASE3Recruiting
92 participants
Started: Aug 29, 2024 · Completed: Aug 31, 2026
3 conditions1 sponsor14 locations
NCT06676787
Evaluating the Impact of Demand-Side Incentives (DSI) on Zero Dose Burden and Immunisation Coverage in Nigeria
EARLY_PHASE1Recruiting
100,000 participants
Started: Aug 29, 2024 · Completed: Dec 31, 2025
1 condition3 sponsors2 locations
NCT06440057
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.
PHASE1/PHASE2Recruiting
78 participants
Started: Aug 29, 2024 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06581471
The TRICURE EU Pivotal Study
NARecruiting
80 participants
Started: Aug 29, 2024 · Completed: Dec 30, 2030
3 conditions1 sponsor8 locations
NCT06505109
OPTImizing CArdiac REhabilitation by REfining Sleep and STress
NARecruiting
200 participants
Started: Aug 28, 2024 · Completed: Jan 31, 2027
2 conditions4 sponsors3 locations
NCT06351592
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
PHASE1Recruiting
42 participants
Started: Aug 28, 2024 · Completed: Apr 26, 2029
2 conditions1 sponsor14 locations
NCT06673953
Effect of Respiratory Trainer on Cardiopulmonary Functions in Patients with Upper Cross Syndrome Post-Cardiac Surgery
NARecruiting
60 participants
Started: Aug 28, 2024 · Completed: Feb 25, 2025
5 conditions1 sponsor1 location
NCT06050200
TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery
NARecruiting
154 participants
Started: Aug 28, 2024 · Completed: May 31, 2029
4 conditions2 sponsors1 location
NCT06677931
Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Melasma
NARecruiting
60 participants
Started: Aug 28, 2024 · Completed: Aug 1, 2026
1 condition1 sponsor2 locations
NCT05088876
Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control
PHASE4Recruiting
140 participants
Started: Aug 28, 2024 · Completed: Jul 31, 2026
1 condition2 sponsors2 locations
NCT06582017
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
PHASE1Recruiting
100 participants
Started: Aug 28, 2024 · Completed: May 30, 2028
9 conditions1 sponsor8 locations
NCT06580652
Respiratory Parameters Using Advanced Airways During In-hospital Cardiac Arrest
N/ARecruiting
30 participants
Started: Aug 28, 2024 · Completed: Oct 1, 2025
1 condition2 sponsors1 location
NCT06275776
HIP-STITCH (Wound Recovery After THA)
NARecruiting
236 participants
Started: Aug 28, 2024 · Completed: May 1, 2028
1 condition1 sponsor1 location
NCT06581315
Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma
NARecruiting
204 participants
Started: Aug 28, 2024 · Completed: Aug 30, 2032
2 conditions1 sponsor1 location
NCT06577233
Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis
PHASE4Recruiting
60 participants
Started: Aug 28, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06416150
Reducing Urban Cervical Cancer Disparities
NARecruiting
546 participants
Started: Aug 28, 2024 · Completed: Dec 31, 2027
2 conditions5 sponsors3 locations
NCT06718517
Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-based Regimen
N/ARecruiting
65 participants
Started: Aug 28, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06318871
Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma
EARLY_PHASE1Recruiting
10 participants
Started: Aug 28, 2024 · Completed: May 28, 2030
5 conditions2 sponsors2 locations
NCT06719310
Phase Ib/IIa Clinical Study of ACC017 Tablets
PHASE1/PHASE2Recruiting
36 participants
Started: Aug 28, 2024 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT06450197
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
PHASE2Recruiting
192 participants
Started: Aug 28, 2024 · Completed: Aug 2, 2027
1 condition1 sponsor191 locations
NCT06484179
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
NARecruiting
100 participants
Started: Aug 28, 2024 · Completed: Jul 31, 2027
2 conditions2 sponsors1 location
NCT06480227
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
NARecruiting
358 participants
Started: Aug 28, 2024 · Completed: Aug 1, 2029
3 conditions10 sponsors7 locations